ISLAMABAD – Pakistan is set to commence local insulin production through a strategic partnership with Russia, aiming to enhance self-reliance in the pharmaceutical sector and reduce dependency on expensive imports. The initiative was discussed in a high-level meeting chaired by Special Assistant to the Prime Minister on Finance, Haroon Akhtar, involving officials from the Drug Regulatory Authority of Pakistan (DRAP) and Russian representatives.
The project will unfold in phases, with large-scale manufacturing anticipated within three years. A key component of the agreement is the transfer of technology, enabling Pakistani experts to gradually scale up production. The collaboration is expected to improve access to insulin for diabetic patients, stimulate business cooperation, and foster scientific research between the two nations.
Haroon Akhtar described the initiative as “the foundation of a new era,” emphasizing its potential to create new opportunities in the pharmaceutical industry. He highlighted that strict compliance with regulatory standards will be essential for the project’s success and sustainability.
This partnership underscores Pakistan’s commitment to self-reliance in essential medicines, aiming to strengthen both healthcare and economic ties with Russia.
This story has been reported by PakTribune. All rights reserved.